Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Novocaine's start to box office life certainly hasn't been easy, with this movie about Jack Quaid's man who feels no pain, ...

Stifel Nicolaus analyst Chris O`Cull maintained a Hold rating on Jack In The Box (JACK – Research Report) yesterday and set a price target of ...

Stifel analyst Chris O’Cull lowered the firm’s price target on Jack in the Box (JACK) to $35 from $40 and keeps a Hold rating on the shares.

Nine months since announcing its intentions, one of the five proposed Jack in the Box locations is coming to Capital Circle ...

We recently published a list of 12 Incredibly Cheap Dividend Stocks to Buy Now. In this article, we are going to take a look ...

Raymond James Financial Inc. acquired a new position in shares of Jack in the Box Inc. (NASDAQ:JACK – Free Report) in the 4th ...

We came across a bullish thesis on Jack in the Box Inc. (JACK) on Substack by Christopher Kirincic. In this article, we will ...

Avantax Advisory Services Inc. decreased its holdings in Jack in the Box Inc. (NASDAQ:JACK – Free Report) by 43.3% in the 4th ...

The company’s previous CEO, Leonard Comma, was at odds with franchisees. After Jack in the Box pivoted its model and significantly reduced the number of company-owned and operated restaurants, ...

Fast food giant Jack in the Box is shutting down locations nationwide. Per Mashed, in February 2025 the company announced the ...

“Novocaine” only cost $18 million to produce, so (like its main character) it shouldn’t be feeling any pain at the box office ...